Thyroid storm
ICD-10 E05.5 · ICD-11 5A02.5

Thyroid Storm Not Responding to Initial Multimodality Therapy: What to Do Next

Clinical Scenario

This protocol addresses thyroid storm that has not adequately responded to first-line multimodality treatment. When the initial combined pharmacological approach fails to bring the patient's condition under control within the expected timeframe, escalation to a more intensive intervention is required.

Previous Line — Failure Condition

First-line therapy for thyroid storm involves a combination of an antithyroid drug, inorganic iodide, a corticosteroid, a beta-adrenergic antagonist, acetaminophen, and mechanical cooling. The targets for that line are heart rate controlled to ≤130 bpm and improvement in thyrotoxic symptoms — including tachycardia, high fever, and disturbances of consciousness — within 12–24 hours. When these targets are not reached, this next-step protocol applies.

Next-Step Approach (Partial Overview)

The approach at this stage centres on extracorporeal blood purification. Therapeutic plasmapheresis (TPE) is the primary intervention, carried out using fresh frozen plasma as the replacement solution. In patients with haemodynamic instability or severe systemic complications, TPE may be combined with an additional form of continuous extracorporeal support. The full session parameters, combination criteria, and step-by-step algorithm are available in the complete protocol.

Clinical Goals

Measurable reduction in free triiodothyronine (FT3) and free thyroxine (FT4) levels, together with overall clinical improvement.

Instant Access to Structured Evidence-Based Regimens

References

  1. Therapeutic plasmapheresis (TPE) should be considered if clinical improvement is not noted within 24–48 hours of initial treatment with appropriate doses of ATDs, inorganic iodine, corticosteroids, or beta-AAs, as well as specific treatment for the triggering disease and complications with thyroid storm.
  2. Therefore, it is recommended that FFP be used as the replacement solution in TPE to treat thyroid storm because FFP is expected to reduce thyroid hormones more efficiently than albumin solution.
  3. This study recommended that TPE should be performed daily with 40–50 mL/kg of replacement solution until clinical improvements are noted, and FT3 and FT4 levels should be sampled before and after each session.
  4. Since CHDF is performed not only for the treatment of acute hepatic and renal failure, but also for the removal of excess cytokines in systemic inflammatory response syndrome (SIRS), the combined use of TPE with CHDF is recommended for patients with severe complications such as multiple organ failure.
  5. TPE should not be dis-continued if there is no reduction in FT3 or FT4 levels because of biologico-clinical dissociation.
View source ↗